This website uses cookies to improve functionality and performance. We sometimes share information on how people use our site with third parties, including social media websites for advertising and marketing purposes. By continuing to browse the site or clicking “I accept cookies”, you agree to our use of cookies. You can manage or remove cookie settings and find further information by visiting our cookie information page.
Hi there, we see you're using OS, why not try our app?
Download
Skip to main content
1

14 October update on NHSBT's state of readiness for EU exit

Read our update

Component portfolio and prices

Portfolio 

Portfolio of blood components and guidance 

This provides details of therapeutic blood components supplied to hospitals, including constituents, and information on:

  • specifications
  • identification barcodes
  • quality standards and monitoring
  • storage and handling
  • clinical indications and contraindications
  • specialist requirements
  • dosage, administration, recognition of adverse effects
  • material safety data sheet

Prices

Price list 

Availability of non stock  and special components

Availability of non stock and special components including components required for urgent requests. 

SaBTO’s recommendations on vCJD risk reduction measures

NHSBT communication issued 9 September 2019 regarding the Department for Health and Social Care's (DHSC) notification of the ministerial decision to accept SaBTO’s recommendations on vCJD risk reduction measures in England, Wales and Scotland for plasma and platelet recipients born on or after 1 January 1996.